Medico-economic Impact Evaluation in Telemedecine Follow-up in Complement of a Mobile Team in Patients With Neurological Disabilities (HANDI@CCESS)

Sponsor
Pôle Saint Hélier (Other)
Overall Status
Completed
CT.gov ID
NCT03717974
Collaborator
Clinique Mutualiste la Sagesse (Other)
80
1
2
40
2

Study Details

Study Description

Brief Summary

Access to care for people with traumatic or degenerative neurological disabilities is a current public health concern. New technological tools such as telemedicine can bring expertise to the place of life of people while promoting the city-hospital link.

Condition or Disease Intervention/Treatment Phase
  • Other: Telemedecine follow-up after an intervention at home of the mobile team
  • Other: Mobile team follow-up after an intervention at home of the mobile team
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Monocentric, randomized controlled pilot studyMonocentric, randomized controlled pilot study
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Randomized Controlled Pilot Study for Medico-economic Impact Evaluation in Telemedecine Follow-up in Complement of a Mobile Team in Patients With Neurological Disabilities (HANDI@CCESS)
Actual Study Start Date :
Sep 24, 2018
Actual Primary Completion Date :
Nov 22, 2021
Actual Study Completion Date :
Jan 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: telemedecine's follow-up

Telemedecine follow-up after an intervention at home of the mobile team

Other: Telemedecine follow-up after an intervention at home of the mobile team
After a first visit of the mobile team at home, patients are followed by telemedicine. Moreover, in case of pain, a specialized consultation by an algologist of "La Sagesse" will be realized.
Other Names:
  • medico-economic analysis
  • Active Comparator: mobile team's follow-up

    Mobile team follow-up after an intervention at home of the mobile team

    Other: Mobile team follow-up after an intervention at home of the mobile team
    After a first visit of the mobile team at home, patients are followed by mobile team. Moreover, in case of pain, a specialized consultation by an algologist of "La Sagesse" will be realized.
    Other Names:
  • medico-economic analysis
  • Outcome Measures

    Primary Outcome Measures

    1. Medical-economic analysis by the calculation of the cost-effectiveness of this organization of care [6 months]

      Cost-effectiveness analysis by ICER (Incremental Cost-Effectiveness Ratio)

    Secondary Outcome Measures

    1. UTAUT (Unified theory of acceptance of technology) questionnaire [6 months]

      Questionnaire of acceptability / acceptance of the tool and its use by professionals based on the Unified Theory of Acceptance and Use Technology (UTAUT)

    2. Hospital Anxiety and Depression scale (HAD) [6 months]

      It can detect anxiety and depressive disorders. It has 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), thus obtaining two scores (maximum score of each score = 21). 7 or less: no symptomatology 8 to 10: doubtful symptomatology 11 and above: certain symptomatology.

    3. Pain evaluation [6 months]

      Digital assessment (0 to 10) of pain for communicating patients

    4. DN4 scale [6 months]

      Digital assessment of neuropathic pain for communicating patients. If the patient score is equal to or greater than 4/10, the test is positive.

    5. Doloplus scale [6 months]

      Behavioral Assessment Scale of Pain in Older People with Verbal Communication Disorders. This scale comprises ten items divided into three subgroups (five somatic, two psychomotor and three psychosocial). Each item is rated from 0 to 3 (four exclusive and progressive level scoring), which results in an overall score between 0 and 30. The pain is clearly affirmed for a score greater than or equal to 5 out of 30.

    6. Zarit's score [6 months]

      The Zarit scale assesses the emotional, physical and financial burden for caregivers of caring for someone with a loss of autonomy. The total score, which is the sum of the scores obtained for each of 22 items, varies from 0 to 88. A score less than or equal to 20 indicates a low or no load; a score between 21 and 40 indicates a light load; a score between 41 and 60 indicates a moderate load; a score above 60 indicates a severe charge.

    7. Goal Attainment Scale [6 months]

      Goal Attainment Scale by objectives at the beginning and end of taking charge. Each item built has 5 levels of answers 0: corresponds to the achievement of the goal set by the examiner. 1: is a better score than expected. 2: corresponds to the most favorable evolution expected. 1: corresponds to a score lower than that expected. 2: corresponds to a least favorable score expected.

    8. EVA Satisfaction [6 months]

      Digital assessment (0 to 10) of satisfaction.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients over 18

    • Volunteer to participate in the study and whose primary caregiver is voluntary

    • Presenting a severe neurological handicap following a neurological lesion of traumatic, vascular or degenerative origin,

    • Requiring an expert opinion in MPR (rehabilitation, technical and human compensatory means, specific treatments ...) and / or in algology

    • Whose access to care is reduced (difficulties of movement, distance from expert centers, situation of fragility ...) and which necessitate the displacement of professionals at home,

    • Which require a coordination of care associating the professionals of the sanitary and medico-social sectors

    • Living in health territory 5 in Brittany

    • Mastering the French language spoken and / or written.

    Exclusion Criteria:
    • Misunderstanding making it impossible for informed consent with the refusal of the guardian or court safeguard

    • Unable to use a digital tablet or lack of a resource person who can assist the patient in the use of the tablet

    • Patients who do not have access to an internet connection (white area)

    • Life threatening is committed in the short term (< 3 months)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Pôle Saint-Hélier Rennes France 35000

    Sponsors and Collaborators

    • Pôle Saint Hélier
    • Clinique Mutualiste la Sagesse

    Investigators

    • Principal Investigator: Philippe Gallien, Doctor, Pole Saint-Hélier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pôle Saint Hélier
    ClinicalTrials.gov Identifier:
    NCT03717974
    Other Study ID Numbers:
    • 2017-A02378-45
    First Posted:
    Oct 24, 2018
    Last Update Posted:
    Feb 11, 2022
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Pôle Saint Hélier

    Study Results

    No Results Posted as of Feb 11, 2022